Should a biotech hand its molecule to a single integrated partner, or build a network of specialists around it? Manufacturers and clinical providers are answering in both directions at once: some are adding capabilities and integrating more of the development chain, while others are narrowing their focus and relying on specialist partners. Whichever it picks, the biotech answers for what happens between its suppliers.